EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolomic Insight into Implications of Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Locally Advanced Head and Neck Cancer

Łukasz Boguszewicz iD, Agata Bieleń iD, Mateusz Ciszek, Agnieszka Skorupa, Jolanta Mrochem-Kwarciak, Krzysztof Składowski, Maria Sokół iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms25010188 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Łukasz Boguszewicz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland. Hauptthemen laut MEDLINE: Induction Chemotherapy, Head and Neck Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study compares two groups of locally advanced patients with head and neck squamous cell carcinoma (LA-HNSCC) undergoing concurrent chemoradiotherapy (cCHRT), specifically those for whom it is a first-line treatment and those who have previously received induction chemotherapy (iCHT). The crucial question is whether iCHT is a serious burden during subsequent treatment for LA-HNSCC and how iCHT affects the tolerance to cCHRT. Of the 107 LA-HNSCC patients, 54 received cisplatin-based iCHT prior to cCHRT. The patients were clinically monitored at weekly intervals from the day before until the completion of the cCHRT. The 843 blood samples were collected and divided into two aliquots: for laboratory blood tests and for nuclear magnetic resonance (NMR) spectroscopy (a Bruker 400 MHz spectrometer). The NMR metabolites and the clinical parameters from the laboratory blood tests were analyzed using orthogonal partial least squares analysis (OPLS) and the Mann–Whitney U test (MWU). After iCHT, the patients begin cCHRT with significantly (MWU p-value < 0.05) elevated blood serum lipids, betaine, glycine, phosphocholine, and reticulocyte count, as well as significantly lowered NMR inflammatory markers, serine, hematocrit, neutrophile, monocyte, red blood cells, hemoglobin, and CRP. During cCHRT, a significant increase in albumin and psychological distress was observed, as well as a significant decrease in platelet, N-acetyl-cysteine, tyrosine, and phenylalanine, in patients who received iCHT. Importantly, all clinical symptoms (except the decreased platelets) and most metabolic alterations (except for betaine, serine, tyrosine, glucose, and phosphocholine) resolve until the completion of cCHRT. In conclusion, iCHT results in hematological toxicity, altered lipids, and one-carbon metabolism, as well as downregulated inflammation, as observed at the beginning and during cCHRT. However, these complications are temporary, and most of them resolve at the end of the treatment. This suggests that iCHT prior to cCHRT does not pose a significant burden and should be considered as a safe treatment option for LA-HNSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induction ChemotherapyHead and Neck NeoplasmsHumansSquamous Cell Carcinoma of Head and NeckPhosphorylcholineChemoradiotherapyBetaineSerineTyrosineLipids

Stichwörter der Autor:innen

LA-HNSCCNMR spectroscopychemoradiotherapyhead and neck cancerinduction chemotherapymetabolomicstreatment toxicity

Substanzen

PhosphorylcholineBetaineSerineTyrosineLipids

Autor:innen und Institutionen

  • Department of Medical Physics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
  • 1st Radiation and Clinical Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
  • Analytics and Clinical Biochemistry Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.

ORCID-Profile: Łukasz Boguszewicz, Agata Bieleń, Maria Sokół

Zitieren

APA

Boguszewicz, Ł., Bieleń, A., Ciszek, M., Skorupa, A., Mrochem-Kwarciak, J., Składowski, K., & Sokół, M. (2023). Metabolomic Insight into Implications of Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Locally Advanced Head and Neck Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25010188

Vancouver

Boguszewicz Ł, Bieleń A, Ciszek M, Skorupa A, Mrochem-Kwarciak J, Składowski K, et al. Metabolomic Insight into Implications of Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Locally Advanced Head and Neck Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms25010188

BibTeX
@article{Boguszewicz2023,
  author = {Boguszewicz, Łukasz and Bieleń, Agata and Ciszek, Mateusz and Skorupa, Agnieszka and Mrochem-Kwarciak, Jolanta and Składowski, Krzysztof and Sokół, Maria},
  title = {Metabolomic Insight into Implications of Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Locally Advanced Head and Neck Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms25010188}
}
Kostenlos starten →